Insights

2 blue chip ASX dividend shares with attractive yields

These blue chips offer attractive yields in this low interest rate environment…
The post 2 blue chip ASX dividend shares with attractive yields appeared first on The Motley Fool Australia. –

While there are hopes that interest rates may now improve sooner than expected, this is still like to be a couple of years away.

In light of this, the Australian share market looks likely to be the best place to generate a passive income for the time being. But which dividend shares could be top options? Here are two blue chips to consider:

Australia and New Zealand Banking GrpLtd (ASX: ANZ)

This banking giant certainly has returned to form in FY 2021. Last month ANZ released its half year results and revealed a statutory profit after tax of $2,943 million and cash earnings from continuing operations of $2,990 million. This was up 45% and 28%, respectively, on the second half of FY 2020.

Positively, thanks to favourable trading conditions, a booming housing market, and the relaxation of responsible lending rules, ANZ looks well-placed to build on this in the second half and in FY 2022.

Analysts at Morgans are very bullish on the bank. They currently have an add rating and $34.50 price target on its shares.

The broker is also forecasting fully franked dividends of 145 cents per share in FY 2021 and 163 cents per share in FY 2022. Based on the latest ANZ share price of $28.98, this represents yields of 5% and 5.6%, respectively.

Sonic Healthcare Limited (ASX: SHL)

Sonic Healthcare is one of the world’s leading healthcare providers, with operations in Australasia, Europe and North America. It currently employs more than 1,500 pathologists and radiologists, and more than 10,000 medical scientists, radiographers, sonographers, technicians, and nurses.

Sonic has been a particularly positive performer in FY 2021 thanks to increased demand for COVID-19 testing. This led to the company reporting a 33% increase in first half revenue to $4.4 billion and a massive 166% increase in first half net profit to $678 million.

A similarly strong second half is expected. And with COVID testing demand expected to remain high into 2022, it looks well-placed to continue its positive form into FY 2022.

Credit Suisse is a fan of the company. Its analysts currently have an overweight rating and $40.00 price target on its shares. The broker is forecasting dividends of 97 cents per share in FY 2021 and 98 cents per share in FY 2022. Based on the latest Sonic share price of $37.81, this will mean yields of 2.55% and 2.6%, respectively.

The post 2 blue chip ASX dividend shares with attractive yields appeared first on The Motley Fool Australia.

These Dividend Stocks Could Be Your Next Cash Kings (FREE REPORT)

Motley Fool Australia’s Dividend experts recently released a brand-new FREE report revealing 3 dividend stocks with JUICY franked dividends that could keep paying you meaty dividends for years to come.

Our team of investors think these 3 dividend stocks should be a ‘must consider’ for any savvy dividend investor. But more importantly, could potentially make Australian investors a heap of passive income.

Don’t miss out! Simply click the link below to grab your free copy and discover these 3 high conviction stocks now.

Returns As of 15th February 2021

More reading

Did CBA (ASX:CBA) just make it harder to get a home loan?
Brokers name 3 ASX shares to buy today

ASX 200 drops, Sonic acquires, Challenger down

CBA (ASX:CBA) and other banks hit by internet outage
Up 27% this year, is the ANZ (ASX:ANZ) share price still a buy?

James Mickleboro does not own any shares mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!